Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Rattigan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Cell and Developmental Biology|October 16, 2018
The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for ThoughtAngela Ianniciello, Kevin M Rattigan, G Vignir Helgason
Blood|January 12, 2023
Metabolism in stem cell-driven leukemia: parallels between hematopoiesis and immunityKevin M Rattigan, Martha M Zarou, G Vignir Helgason
Rheumatology (Oxford, England)|September 10, 2019
The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretionLewis C Rodgers, John Cole, Kevin M Rattigan, et al.
Plos One|March 15, 2018
Metabolomic profiling of macrophages determines the discrete metabolomic signature and metabolomic interactome triggered by polarising immune stimuliKevin M Rattigan, Andrew W Pountain, Clement Regnault, et al.
Nature Communications|March 2, 2024
Inhibition of mitochondrial folate metabolism drives differentiation through mTORC1 mediated purine sensingMartha M Zarou, Kevin M Rattigan, Daniele Sarnello, et al.
Science Translational Medicine|September 29, 2021
ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapyAngela Ianniciello, Martha M Zarou, Kevin M Rattigan, et al.
EMBO Reports|July 25, 2023
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cellsKevin M Rattigan, Martha M Zarou, Zuzana Brabcova, et al.
Nature Communications|August 17, 2023
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cellsKevin M Rattigan, Zuzana Brabcova, Daniele Sarnello, et al.
Blood|February 24, 2026
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemiaEkaterini Himonas, Lucie de Beauchamp, Désirée Zerbst, et al.
Cancer Letters|May 7, 2026
FGFR1 drives metabolic adaptation associated with temozolomide resistance in glioblastomaLaura Zarzuela, Ignacio G López-Cepero, Kevin M Rattigan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Cell and Developmental Biology|October 16, 2018
The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for ThoughtAngela Ianniciello, Kevin M Rattigan, G Vignir Helgason
Blood|January 12, 2023
Metabolism in stem cell-driven leukemia: parallels between hematopoiesis and immunityKevin M Rattigan, Martha M Zarou, G Vignir Helgason
Rheumatology (Oxford, England)|September 10, 2019
The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretionLewis C Rodgers, John Cole, Kevin M Rattigan, et al.
Plos One|March 15, 2018
Metabolomic profiling of macrophages determines the discrete metabolomic signature and metabolomic interactome triggered by polarising immune stimuliKevin M Rattigan, Andrew W Pountain, Clement Regnault, et al.
Nature Communications|March 2, 2024
Inhibition of mitochondrial folate metabolism drives differentiation through mTORC1 mediated purine sensingMartha M Zarou, Kevin M Rattigan, Daniele Sarnello, et al.
Science Translational Medicine|September 29, 2021
ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapyAngela Ianniciello, Martha M Zarou, Kevin M Rattigan, et al.
EMBO Reports|July 25, 2023
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cellsKevin M Rattigan, Martha M Zarou, Zuzana Brabcova, et al.
Nature Communications|August 17, 2023
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cellsKevin M Rattigan, Zuzana Brabcova, Daniele Sarnello, et al.
Blood|February 24, 2026
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemiaEkaterini Himonas, Lucie de Beauchamp, Désirée Zerbst, et al.
Cancer Letters|May 7, 2026
FGFR1 drives metabolic adaptation associated with temozolomide resistance in glioblastomaLaura Zarzuela, Ignacio G López-Cepero, Kevin M Rattigan, et al.
Pageof 2